- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Investigation of the Responsiveness to Liver Injury in hL-FABP Tg mice
-
- UNO Kinuko
- Department of Food and Nutritional Science, Graduate School of Agriculture, Tokyo University of Agriculture
-
- MIYAJIMA Katsuhiro
- Department of Food and Nutritional Science, Graduate School of Agriculture, Tokyo University of Agriculture Department of Nutritional Science and Food Safety, Graduate School of Agriculture, Tokyo University of Agriculture Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture
-
- RYU Kanjiro
- Department of Nutritional Science and Food Safety, Graduate School of Agriculture, Tokyo University of Agriculture
-
- OHATA Keiichi
- L-FABP Business Department, CMIC Holdings CO., Ltd.
-
- KEMURIYAMA Noriko
- Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture
-
- NAKAE Dai
- Department of Food and Nutritional Science, Graduate School of Agriculture, Tokyo University of Agriculture Department of Nutritional Science and Food Safety, Graduate School of Agriculture, Tokyo University of Agriculture Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture
Bibliographic Information
- Other Title
-
- hL-FABP Tgマウスの肝障害に対する反応性の検討
Description
<p>Liver-derived L-FABP is reported to be a potential of disease biomarker for NAFLD/ NASH and viral hepatitis in human patients. CCl4 was administrated subcutaneously once to hL-FABP Tg mice at the dose levels of 2.5, 5 and 10 mL/kg. After 24, 48 and 72 hours of administration, the hepatotoxicity and levels of serum hL-FABP were evaluated. hL-FABP was reached the maximum levels at 24 hours after dosing and then decreased over time with dose-dependently, however, there was no difference in hepatological features at all levels. And the protein expression of hL-FABP in the liver was enhanced over time. The mechanism of these changes will be analyzed.</p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 47.1 (0), P-78S-, 2020
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390285697591779712
-
- NII Article ID
- 130007898539
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed